Cyclin Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BCL2 Inhibitor Venetoclax in Experimental Models of Mantle Cell Lymphoma Without RB1 Deletion
Experimental hematology & oncology(2024)
关键词
Cyclin-dependent kinase (CDK) inhibitors,Palbociclib,BCL2,Venetoclax,RB1,Mantle cell lymphoma (MCL)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要